Buyout firm Advent International plans to sell a majority stake in U.S.-based Bioduro-Sundia in a deal that could value the drug development and manufacturing outsourcing provider at over $1 billion, said three people...
Intas & Dr Reddy’s in race with PEs to buy US’ Athenex
India’s Intas Pharmaceuticals and Dr Reddy’s Laboratories are in talks to acquire Athenex Inc in a $200-250 million (₹1,580-1,980 crore) deal, as the US-based biotechnology firm looks to sell a controlling...
LIC reduces stake by 2% in Sun Pharma to 5.024%
Life insurance giant, LIC on Monday announced offloading of a portion of its stake in pharma major, Sun Pharmaceuticals Industries. LIC has trimmed its stake by 2.002% in the pharma company. Both LIC and Sun Pharma...
GSK spins off $36 billion consumer-healthcare business Haleon
GSK PLC completed the spinoff of its consumer-healthcare business, a bet that greater focus on innovative drugs and vaccines will help accelerate growth at the pharmaceuticals giant. The new stand-alone company, called...
Piramal Enterprises gets shareholders’ nod to demerge pharma business
Ajay Piramal-owned Piramal Enterprises has received shareholders’ approval to demerge its pharmaceuticals business and simplify the corporate structure. The company received 99 per cent of the votes at the shareholders...
Merck in advanced talks to buy Seagen in nearly $40-bln deal – WSJ
Drugmaker Merck & Co is in advanced talks to buy cancer-focused biotech company Seagen Inc in a deal that could be worth roughly $40 billion or more, the Wall Street Journal reported. The companies are discussing a...
Brazilian pharma Hypera in merger talks with Grupo NC – media report
Brazilian drugmaker Hypera SA is in talks to merge with conglomerate Grupo NC, according to a Tuesday report from business newspaper Valor Economico. Under the potential deal, Hypera would become part of Grupo NC, which...
Walgreens defers Boots UK sale; Reliance to look for other opportunities
American retail major Walgreens Boots Alliance on Tuesday said it would retain its pharma retail business — Boots UK — thus abandoning the entire sale process. The company did not make any comment specifically on the...
Glenmark Pharma’s US arm acquires four OTC drugs from Wockhardt
Glenmark Pharmaceuticals Ltd. said its US subsidiary has acquired generic versions of four over-the-counter drugs from Wockhardt Ltd. The acquisition includes approved Abbreviated New Drug Applications (ANDAs) for...
Cipla buys additional stake in digital health company GoApptiv
Drugmaker Cipla said that it has agreed to acquire an additional stake in digital tech company GoApptiv for Rs 25.90 crore. Post completion of the deal, Cipla’s total stake in GoApptiv will increase to 22.02% on a fully...
RIL in talks to raise up to $8 bn for Boots deal
Reliance Industries Ltd (RIL) is in talks with a clutch of global banks to raise $8 billion for its planned leveraged buyout of British pharma chain Boots, two people aware of the discussions said. The conglomerate, led...
DRL acquires injectable portfolio from US-based Eton Pharma for $50 million
Dr. Reddy’s announced that it has acquired a portfolio of branded and generic injectable products from Deer Park, Illinois, based Eton Pharmaceuticals. Under the terms of the agreement, Dr. Reddy’s will pay $5 million...
